{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:00:55Z","timestamp":1790438455205,"version":"4.1.0"},"reference-count":282,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.intimp.2026.117240","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:32:38Z","timestamp":1786638758000},"page":"117240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Gut microbiota-derived TMA\/TMAO and IRAK4 signaling in type 2 diabetes: Current evidence, knowledge gaps and future therapeutic opportunities"],"prefix":"10.1016","volume":"188","author":[{"given":"Arnabjyoti Deva","family":"Sarma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moitrayee","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117240_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications [internet]","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2026.117240_bb0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/abm-2020-0034","article-title":"IRAK inhibitor can improve insulin sensitivity in insulin-resistant mice fed with a high-fat diet","volume":"14","author":"Allahyari","year":"2020","journal-title":"Asian Biomed."},{"issue":"12","key":"10.1016\/j.intimp.2026.117240_bb0015","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/s42255-025-01413-8","article-title":"Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic control","volume":"7","author":"Chilloux","year":"2025","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0020","article-title":"Identification of HDAC9 and ARRDC4 as potential biomarkers and targets for treatment of type 2 diabetes","volume":"14","author":"Liu","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12915-023-01578-2","article-title":"Indoleacrylic acid produced by Parabacteroides distasonis alleviates type 2 diabetes via activation of AhR to repair intestinal barrier","volume":"21","author":"Liu","year":"2023","journal-title":"BMC Biol."},{"key":"10.1016\/j.intimp.2026.117240_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117240_bb0035","doi-asserted-by":"crossref","first-page":"1765794","DOI":"10.3389\/fcdhc.2026.1765794","article-title":"Integrating TMAO into the pathogenesis of obesity and type 2 diabetes: a mini review","volume":"28","author":"Stoian","year":"2026","journal-title":"Front. Clin. Diabetes Healthcare"},{"key":"10.1016\/j.intimp.2026.117240_bb0050","series-title":"IntechOpen eBooks","article-title":"Exploring the function of inflammatory routes in insulin resistance: interpreting the inflammatory veil of medusa","author":"Kumari","year":"2024"},{"issue":"9","key":"10.1016\/j.intimp.2026.117240_bb0060","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2337\/dbi24-0028","article-title":"The gut microbiota and diabetes: research, translation, and clinical applications\u20142023 diabetes, diabetes care, and diabetologia expert forum","volume":"73","author":"Byndloss","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2026.117240_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22727-7","article-title":"Emerging concepts in intestinal immune control of obesity-related metabolic disease [internet]","author":"Khan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117240_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-025-02368-9","article-title":"Immuno-metabolic diseases and therapeutics: molecular mechanisms via inflammasome signaling [internet]","author":"Han","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.intimp.2026.117240_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-024-01369-x","article-title":"Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes [internet]","author":"Guan","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.intimp.2026.117240_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/frmbi.2024.1324476","article-title":"Role of pattern recognition receptors and microbiota-derived ligands in obesity","volume":"3","author":"Rolland","year":"2024","journal-title":"Front. Microbiomes"},{"key":"10.1016\/j.intimp.2026.117240_bb0125","first-page":"573","article-title":"Metabolism and metabolic disorders and the microbiome: the intestinal microbiota associated with obesity, lipid metabolism, and metabolic health\u2014pathophysiology and therapeutic strategies [Internet]","author":"Aron-Wisnewsky","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2026.117240_bb0130","article-title":"Adipose tissue macrophages as potential targets for obesity and metabolic diseases [internet]","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0135","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s40200-021-00858-4","article-title":"Intestinal microbiota and their metabolic contribution to type 2 diabetes and obesity [internet]","author":"Cunningham","year":"2021","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.intimp.2026.117240_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/s13099-021-00446-0","article-title":"Gut microbiota influence in type 2 diabetes mellitus (T2DM) [Internet]","author":"Cunningham","year":"2021","journal-title":"Gut Pathog."},{"key":"10.1016\/j.intimp.2026.117240_bb0105","article-title":"Enhancing intestinal barrier efficiency: a novel metabolic diseases therapy [internet]","author":"Zhang","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2026.117240_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1291853","article-title":"Exploring a novel therapeutic strategy: the interplay between gut microbiota and high-fat diet in the pathogenesis of metabolic disorders","volume":"10","author":"Jia","year":"2023","journal-title":"Front. Nutr."},{"issue":"21","key":"10.1016\/j.intimp.2026.117240_bb0080","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162291","article-title":"Effect of acute TLR4 inhibition on insulin resistance in humans","volume":"132","author":"Liang","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.117240_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12272-021-01307-9","article-title":"Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases [internet]","author":"Seok","year":"2021","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.intimp.2026.117240_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00062","article-title":"Mechanisms of macrophage polarization in insulin signaling and sensitivity [internet]","author":"Orliaguet","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb0095","series-title":"IRF5 and the Metabolic Adaptations of Adipose Tissue Macrophages Upon Metabolic Stress","author":"Orliaguet","year":"2026"},{"key":"10.1016\/j.intimp.2026.117240_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.632335","article-title":"Modulating the microbiota as a therapeutic intervention for type 2 diabetes [internet]","author":"Huda","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb0070","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s00125-020-05268-4","article-title":"Intestinal microbial metabolites in human metabolism and type 2 diabetes [Internet]","author":"Herrema","year":"2020","journal-title":"Diabetologia"},{"issue":"14","key":"10.1016\/j.intimp.2026.117240_bb0100","doi-asserted-by":"crossref","first-page":"1232629","DOI":"10.3389\/fimmu.2023.1232629","article-title":"Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities","volume":"20","author":"Ortega","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18528-z","article-title":"Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development [internet]","author":"Ambati","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117240_bb0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1101\/gad.346312.120","article-title":"Chronic tissue inflammation and metabolic disease [Internet]","author":"Lee","year":"2021","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.intimp.2026.117240_bb0090","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes","volume":"29","author":"Zatterale","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2026.117240_bb0150","first-page":"15","article-title":"Insulin resistance: from mechanisms to therapeutic strategies [internet]","author":"Lee","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.intimp.2026.117240_bb0155","series-title":"Innate Immunity in Health And Disease","year":"2021"},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0160","article-title":"Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity","volume":"9","author":"Semo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13568-023-01520-3","article-title":"The gut microbiota pathway mechanisms of diabetes","volume":"13","author":"Bajinka","year":"2023","journal-title":"AMB Express"},{"key":"10.1016\/j.intimp.2026.117240_bb0170","article-title":"The crucial role and mechanism of insulin resistance in metabolic disease [internet]","author":"Zhao","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1463958","article-title":"The gut-brain-metabolic axis: exploring the role of microbiota in insulin resistance and cognitive function [internet]","author":"Abildinova","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb0180","doi-asserted-by":"crossref","first-page":"344","DOI":"10.15403\/jgld-4248","article-title":"Enhancing metformin effects by adding gut microbiota modulators to ameliorate the metabolic status of obese, insulin-resistant hosts [internet]","author":"Seicaru","year":"2022","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"10.1016\/j.intimp.2026.117240_bb0185","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.2147\/DDDT.S334325","article-title":"New insights of anti-hyperglycemic agents and traditional Chinese medicine on gut microbiota in type 2 diabetes [Internet]","author":"Chen","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.intimp.2026.117240_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1661603","article-title":"Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches [internet]","author":"Hamooya","year":"2025","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36549-2","article-title":"Phosphoproteomics reveals rewiring of the insulin signaling network and multi-nodal defects in insulin resistance","volume":"14","author":"Fazakerley","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117240_bb0200","first-page":"279","article-title":"Cell death and inflammation during obesity: \u201cknow my methods, WAT(son)\u201d [Internet]","author":"Hildebrandt","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2026.117240_bb0205","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy [internet]","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"21","key":"10.1016\/j.intimp.2026.117240_bb0210","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151818","article-title":"Signaling defects associated with insulin resistance in nondiabetic and diabetic individuals and modification by sex","volume":"131","author":"Haider","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.intimp.2026.117240_bb0215","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2024.13219","article-title":"Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation-mediating treatment options (review)","volume":"29","author":"Varra","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2026.117240_bb0220","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40292-020-00408-8","article-title":"Insulin resistance the hinge between hypertension and type 2 diabetes [internet]","author":"Mancusi","year":"2020","journal-title":"High Blood Press. Cardiovasc. Prev."},{"issue":"3","key":"10.1016\/j.intimp.2026.117240_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s43152-024-00056-3","article-title":"Cellular and molecular mechanisms of insulin resistance","volume":"5","author":"Chandrasekaran","year":"2024","journal-title":"Curr. Tissue Microenviron. Rep."},{"key":"10.1016\/j.intimp.2026.117240_bb0230","series-title":"Characterization, and strategies for resolution, of aberrant endothelial function in patients with type 2 diabetes: implications for wound healing","author":"Shadiow","year":"2023"},{"key":"10.1016\/j.intimp.2026.117240_bb0235","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11154-020-09545-w","article-title":"Type 2 diabetes \u2013 unmet need, unresolved pathogenesis, mTORC1-centric paradigm [Internet]","author":"Bar-Tana","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.intimp.2026.117240_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/s40001-023-01424-9","article-title":"Crosstalk between autophagy and insulin resistance: evidence from different tissues [internet]","author":"Sadeghi","year":"2023","journal-title":"Eur. J. Med. Res."},{"issue":"12","key":"10.1016\/j.intimp.2026.117240_bb0245","article-title":"Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites","volume":"5","author":"Russo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0250","article-title":"Diabetes and sarcopenic obesity: pathogenesis, diagnosis, and treatments [internet]","author":"Wang","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb0255","doi-asserted-by":"crossref","first-page":"102131","DOI":"10.1016\/j.arr.2023.102131","article-title":"On the wake of metformin: do anti-diabetic SGLT2 inhibitors exert anti-aging effects?","volume":"92","author":"Scisciola","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.intimp.2026.117240_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.991716","article-title":"How dysregulation of the immune system promotes diabetes mellitus and cardiovascular risk complications [internet]","author":"Girard","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0265","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-023-01043-8","article-title":"Reversing pancreatic \u03b2-cell dedifferentiation in the treatment of type 2 diabetes [internet]","author":"Son","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1161521","article-title":"Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments [internet]","author":"Ruze","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb0275","first-page":"4","article-title":"Innate immune cells in the adipose tissue in health and metabolic disease [internet]","author":"Michailidou","year":"2021","journal-title":"J. Innate Immun."},{"issue":"10","key":"10.1016\/j.intimp.2026.117240_bb0280","first-page":"448","article-title":"Obesity-induced inflammation and its role in the development of insulin resistance","volume":"4","author":"Abdullah","year":"2024","journal-title":"J. Health Sci."},{"key":"10.1016\/j.intimp.2026.117240_bb0285","doi-asserted-by":"crossref","DOI":"10.34172\/apb.025.43911","article-title":"Localized semaglutide injection for hyperinsulinemia-induced lymphatic dysfunction: a narrative review proposing a promising metabolic perspective for lymphedema therapy [internet]","author":"Akl","year":"2025","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.intimp.2026.117240_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1661563","article-title":"Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndrome","volume":"12","author":"Nzobokela","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0295","series-title":"IntechOpen eBooks","article-title":"Introductory chapter: An overview of metabolic syndrome and its prevention","author":"Shiomi","year":"2022"},{"issue":"13","key":"10.1016\/j.intimp.2026.117240_bb0300","article-title":"Adipose tissue macrophage in obesity-associated metabolic diseases","volume":"2","author":"Yao","year":"2022","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.intimp.2026.117240_bb0305","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.3390\/jcm11154358","article-title":"Macrophages, low-grade inflammation, insulin resistance and hyperinsulinemia: a mutual ambiguous relationship in the development of metabolic diseases","volume":"11","author":"P\u00fcschel","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1128622","article-title":"Regulation of the immune system by the insulin receptor in health and disease [internet]","author":"Makhijani","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0315","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15406\/jdmdc.2021.08.00216","article-title":"Targeting macrophage polarization for therapy of diabesity\u2013the feasibility of early improvement of insulin sensitivity and insulin resistance-a comprehensive systematic review","volume":"8","author":"Kaur","year":"2021","journal-title":"J. Diabetes Metabol. Disorders Control"},{"key":"10.1016\/j.intimp.2026.117240_bb0320","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41366-021-00804-7","article-title":"Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics [internet]","author":"Batabyal","year":"2021","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.intimp.2026.117240_bb0325","series-title":"IntechOpen eBooks","article-title":"Phytotherapeutics attenuation of oxidative stress, inflammation and lipid peroxidation in severe and chronic diseases","author":"Mavondo","year":"2021"},{"key":"10.1016\/j.intimp.2026.117240_bb0330","article-title":"Insulin signaling and its application [internet]","author":"TKC","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0335","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-020-00572-w","article-title":"Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications?","volume":"12","author":"Krause","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.intimp.2026.117240_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.00064","article-title":"Organ system crosstalk in cardiometabolic disease in the age of multimorbidity [internet]","author":"Oishi","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1606317","article-title":"Immunometabolic reprogramming in diabetic osteomyelitis: from mechanisms to therapeutics","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117240_bb0350","first-page":"65","article-title":"Adipose tissue immunometabolism: unveiling the intersection of metabolic and immune regulation","volume":"76","author":"Medina-Urrutia","year":"2024","journal-title":"Rev. Investig. Clin."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000521305","article-title":"Immunometabolism: where immunology and metabolism meet","volume":"14","author":"Chavakis","year":"2021","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.intimp.2026.117240_bb0360","article-title":"Effect of natural polyphenols in Chinese herbal medicine on obesity and diabetes: interactions among gut microbiota, metabolism, and immunity","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2026.117240_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.716520","article-title":"Dysbiosis, host metabolism, and non-communicable diseases: trialogue in the inborn errors of metabolism","volume":"12","author":"Montanari","year":"2021","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117240_bb0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41574-024-01059-8","article-title":"Consensus on the key characteristics of metabolism disruptors","volume":"21","author":"La Merrill","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117240_bb0375","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4093\/dmj.2019.0220","article-title":"Revisiting the bacterial phylum composition in metabolic diseases focused on host energy metabolism","volume":"44","author":"Lee","year":"2020","journal-title":"Diabetes Metab. J."},{"issue":"14","key":"10.1016\/j.intimp.2026.117240_bb0380","doi-asserted-by":"crossref","first-page":"1285556","DOI":"10.3389\/fmicb.2023.1285556","article-title":"Immune modulation of gut microbiota and its metabolites in chronic hepatitis B","volume":"29","author":"Li","year":"2023","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202000994","article-title":"Metabolism and inflammation: new synergies and insights","volume":"65","author":"Roche","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.117240_bb0390","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s13668-024-00521-3","article-title":"The interplay between dietary choline and cardiometabolic disorders: a review of current evidence","volume":"13","author":"Vallianou","year":"2024","journal-title":"Curr. Nutri. Reports"},{"key":"10.1016\/j.intimp.2026.117240_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.897462","article-title":"Microbial metabolites in the maturation and activation of dendritic cells and their relevance for respiratory immunity","volume":"13","author":"Wilson","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0400","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41522-022-00352-6","article-title":"Host-microbiome interactions: gut-liver axis and its connection with other organs","volume":"8","author":"Anand","year":"2022","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.intimp.2026.117240_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1085041","article-title":"The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases [internet]","author":"Zhen","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117240_bb0410","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3390\/biom13121692","article-title":"Adipokines and bacterial metabolites: a pivotal molecular bridge linking obesity and gut microbiota Dysbiosis to target","volume":"13","author":"Turpin","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0415","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S0954422420000177","article-title":"TrimethylamineN-oxide: heart of the microbiota\u2013CVD nexus?","volume":"34","author":"Naghipour","year":"2020","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.intimp.2026.117240_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.939571","article-title":"Dietary compounds in modulation of gut microbiota-derived metabolites [internet]","author":"Feng","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2026.117240_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.997056","article-title":"Natural products against inflammation and atherosclerosis: targeting on gut microbiota [internet]","author":"Deng","year":"2022","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117240_bb0430","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00945-21","article-title":"Higher Trimethylamine- N -Oxide plasma levels with increasing age are mediated by diet and Trimethylamine-forming bacteria","volume":"6","author":"Rath","year":"2021","journal-title":"mSystems"},{"key":"10.1016\/j.intimp.2026.117240_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.749125","article-title":"Gut microbiota in adipose tissue dysfunction induced cardiovascular disease: role as a metabolic organ [internet]","author":"Yang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb0440","article-title":"The impact of gut microbiota metabolites on cellular bioenergetics and cardiometabolic health [internet]","author":"Tom\u00e1\u0161ov\u00e1","year":"2021","journal-title":"Nutr. Metab."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0445","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158183","article-title":"Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress\/mitochondrial ROS\/glycolysis pathways","volume":"8","author":"Saaoud","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2026.117240_bb0450","article-title":"Gut metabolite trimethylamine-N-oxide in atherosclerosis: from mechanism to therapy [internet]","author":"Wang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.117240_bb0455","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3390\/nu13082873","article-title":"The accumulation and molecular effects of trimethylamine N-oxide on metabolic tissues: it\u2019s not all bad","volume":"13","author":"Krueger","year":"2021","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.intimp.2026.117240_bb0460","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22844","article-title":"Association of trimethylaminen-oxide and related metabolites in plasma and incident type 2 diabetes","volume":"4","author":"Lema\u00eetre","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0465","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71470-4","article-title":"Metformin decreases bacterial trimethylamine production and trimethylamine N-oxide levels in db\/db mice","volume":"10","author":"Kuka","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0470","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41387-025-00377-8","article-title":"TMAO and diabetes: from the gut feeling to the heart of the problem","volume":"15","author":"Jaworska","year":"2025","journal-title":"Nutri. Diabetes."},{"key":"10.1016\/j.intimp.2026.117240_bb0475","article-title":"Gut macrobiotic and its metabolic pathways modulate cardiovascular disease [internet]","author":"Zhu","year":"2023","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0480","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-39824-4","article-title":"Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide","volume":"14","author":"Andrikopoulos","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117240_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.906310","article-title":"Integrating choline and specific intestinal microbiota to classify type 2 diabetes in adults: a machine learning based metagenomics study","volume":"13","author":"Zeng","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0490","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-63475-w","article-title":"Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study","volume":"10","author":"Calder\u00f3n-P\u00e9rez","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2026.117240_bb0495","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3390\/metabo13121182","article-title":"Bridging the gap from Enterotypes to personalized dietary recommendations: a metabolomics perspective on microbiome research","volume":"13","author":"Bartsch","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.intimp.2026.117240_bb0500","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1170459","article-title":"Dysbiosis signatures of gut microbiota and the progression of type 2 diabetes: a machine learning approach in a Mexican cohort","volume":"14","author":"Neri-Rosario","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0505","doi-asserted-by":"crossref","DOI":"10.1186\/s13765-022-00755-1","article-title":"Effects of SCFAs and TMAO on non-alcoholic fatty liver disease indicating the therapeutic benefits of plant-based diet, and supplemental prebiotics, probiotics and synbiotics","volume":"66","author":"Vu","year":"2023","journal-title":"Appl. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.117240_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.567654","article-title":"Microbial metabolites: critical regulators in NAFLD [internet]","author":"Dai","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb0515","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.964624","article-title":"Implications of trimethylamine N-oxide (TMAO) and betaine in human health: beyond being osmoprotective compounds","author":"Ilyas","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0520","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46829-0","article-title":"Trimethylamine N-oxide impairs \u03b2-cell function and glucose tolerance","volume":"15","author":"Kong","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.intimp.2026.117240_bb0525","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13963","article-title":"Gut microbiota-derived trimethylamine N-oxide and the risk of diabetes: an updated systematic review and meta-analysis","volume":"26","author":"Mohammadi","year":"2025","journal-title":"Obes. Rev."},{"key":"10.1016\/j.intimp.2026.117240_bb0530","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2021.09.026","article-title":"Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome","volume":"335","author":"Ringel","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2026.117240_bb0535","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1360861","article-title":"Trimethylamine N-oxide predicts cardiovascular events in coronary artery disease patients with diabetes mellitus: a prospective cohort study","volume":"15","author":"Yu","year":"2024","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0540","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-022-03581-7","article-title":"Serum trimethylamine-N-oxide is associated with incident type 2 diabetes in middle-aged and older adults: a prospective cohort study","volume":"20","author":"Li","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0545","article-title":"Trimethylamine N-oxide impairs \u03b2-cell function and glucose tolerance","author":"Kong","year":"2023","journal-title":"Research Square (Research Square)."},{"key":"10.1016\/j.intimp.2026.117240_bb0550","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/apm.13038","article-title":"Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide [internet]","author":"Zhu","year":"2020","journal-title":"APMIS"},{"key":"10.1016\/j.intimp.2026.117240_bb0555","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1039\/D0FO01237H","article-title":"Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development [Internet]","author":"Sim\u00f3","year":"2020","journal-title":"Food Funct."},{"issue":"12","key":"10.1016\/j.intimp.2026.117240_bb0560","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3390\/biom11121892","article-title":"Gut metabolite trimethylamine N-oxide protects INS-1 \u03b2-cell and rat islet function under diabetic glucolipotoxic conditions","volume":"11","author":"Krueger","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.117240_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1224982","article-title":"Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes [internet]","author":"Patra","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.intimp.2026.117240_bb0570","article-title":"The gut\u2013adipose\/pancreas axis: a novel perspective on glycolipid metabolism dysregulation in MAFLD and T2DM pathogenesis","volume":"16","author":"Liang","year":"2025","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117240_bb0575","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20232090","article-title":"Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases","volume":"44","author":"Spasova","year":"2024","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.intimp.2026.117240_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1326782","article-title":"Serum levels of trimethylamine N-oxide and kynurenine novel biomarkers are associated with adult metabolic syndrome and its components: a case-control study from the TEC cohort","volume":"11","author":"Mirzababaei","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2026.117240_bb0585","article-title":"Endoplasmic reticulum stress: bridging inflammation and obesity-associated adipose tissue","volume":"15","author":"Ma","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0590","series-title":"AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)","article-title":"In-depth analysis of metabolic phenotype by studying age- and sex-related features of type 2 diabetes","author":"Meix","year":"2021"},{"key":"10.1016\/j.intimp.2026.117240_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1133354","article-title":"Regulation of innate immune signaling by IRAK proteins [internet]","author":"Pereira","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0600","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-01252-z","article-title":"Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy [internet]","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117240_bb0605","first-page":"152","article-title":"The role of cGAS-STING signalling in metabolic diseases: from signalling networks to targeted intervention [internet]","author":"Gong","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2026.117240_bb0610","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-021-00722-1","article-title":"Protein phosphatases in TLR signaling [internet]","author":"Seumen","year":"2021","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.intimp.2026.117240_bb0615","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594150","article-title":"Role of metabolic endotoxemia in systemic inflammation and potential interventions [internet]","author":"Mohammad","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1370042","article-title":"TRIF-dependent signaling and its role in liver diseases","volume":"12","author":"Hu","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.117240_bb0625","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1231749","article-title":"Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4","volume":"14","author":"Cooray","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0630","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17669-5","article-title":"STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1\u03b2 expression","volume":"11","author":"Balic","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117240_bb0635","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.926187","article-title":"Altered inflammatory pathway but unaffected liver fibrosis in mouse models of nonalcoholic steatohepatitis involving Interleukin-1 receptor-associated kinase 1 knockout","volume":"26","author":"Lei","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.intimp.2026.117240_bb0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244570","article-title":"Analysis of interleukin-1 receptor associated kinase-3 (IRAK3) function in modulating expression of inflammatory markers in cell culture models: a systematic review and meta-analysis [internet]","author":"Nguyen","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.intimp.2026.117240_bb0645","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1016\/j.apsb.2024.09.008","article-title":"Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer","volume":"14","author":"Feng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"683","key":"10.1016\/j.intimp.2026.117240_bb0650","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj3289","article-title":"IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases","volume":"15","author":"Lavazais","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0655","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-020-00693-9","article-title":"Phosphatases in toll-like receptors signaling: the unfairly-forgotten [internet]","author":"Lannoy","year":"2021","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.intimp.2026.117240_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1264889","article-title":"Shedding light on the molecular and regulatory mechanisms of TLR4 signaling in endothelial cells under physiological and inflamed conditions [internet]","author":"Stierschneider","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.612452","article-title":"Cross kingdom immunity: the role of immune receptors and downstream signaling in animal and plant cell death [internet]","author":"Roudaire","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0670","article-title":"Targeting toll-like receptor 7\/8 for immunotherapy: recent advances and prospectives [internet]","author":"Sun","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.intimp.2026.117240_bb0675","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST20220271","article-title":"ERK1\/2 in immune signalling [Internet]","author":"Lucas","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.intimp.2026.117240_bb0680","doi-asserted-by":"crossref","first-page":"812774","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity [internet]","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0685","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.756315","article-title":"Toll-like receptors as a therapeutic target in the era of immunotherapies [internet]","author":"Farooq","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.117240_bb0690","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00391-8","article-title":"Exploiting viral sensing mediated by toll-like receptors to design innovative vaccines [internet]","author":"Sartorius","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.intimp.2026.117240_bb0695","doi-asserted-by":"crossref","DOI":"10.1186\/s12979-023-00383-3","article-title":"Toll-like receptor 4 (TLR4): new insight immune and aging","author":"Kim","year":"2023","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.intimp.2026.117240_bb0700","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00018-020-03453-7","article-title":"Infection and atherosclerosis: TLR-dependent pathways [Internet]","author":"Li","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2026.117240_bb0705","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.2147\/DMSO.S279104","article-title":"Toll-like receptor 4 and inflammatory micro-environment of pancreatic islets in type-2 diabetes mellitus: a therapeutic perspective [Internet]","author":"Wang","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.intimp.2026.117240_bb0710","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1042\/CS20190768","article-title":"Nutrient regulation of inflammatory signalling in obesity and vascular disease [Internet]","author":"Palmer","year":"2021","journal-title":"Clin. Sci."},{"key":"10.1016\/j.intimp.2026.117240_bb0715","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2022.12760","article-title":"Interplay of retinol binding protein 4 with obesity and associated chronic alterations (review) [Internet]","author":"Flores-Cortez","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0720","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117240_bb0725","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01191-2","article-title":"Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma [internet]","author":"Xun","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.117240_bb0730","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.606069","article-title":"The anti-inflammatory properties of phytochemicals and their effects on epigenetic mechanisms involved in TLR4\/NF-\u03baB-mediated inflammation [internet]","author":"Saleh","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0735","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.749328","article-title":"Fructose induces visceral adipose tissue inflammation and insulin resistance even without development of obesity in adult female but not in male rats","volume":"8","author":"Kova\u010devi\u0107","year":"2021","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0740","article-title":"Inflammation causes insulin resistance in mice via interferon regulatory factor 3 (IRF3)-mediated reduction in FAHFA levels","volume":"15","author":"Yan","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0745","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34110-1","article-title":"REDD1 promotes obesity-induced metabolic dysfunction via atypical NF-\u03baB activation","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0750","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-86801-2","article-title":"Common genetic variants and pathways in diabetes and associated complications and vulnerability of populations with different ethnic origins","volume":"11","author":"Shoily","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0755","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78376-1","article-title":"Saturated fatty acids induce insulin resistance in podocytes through inhibition of IRS1 via activation of both IKK\u03b2 and mTORC1","volume":"10","author":"Denhez","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2026.117240_bb0760","doi-asserted-by":"crossref","first-page":"226","DOI":"10.18585\/inabj.v14i3.1872","article-title":"The importance of metabolites in modulating insulin sensitivity","volume":"14","author":"Meiliana","year":"2022","journal-title":"Indones. Biomed. J."},{"key":"10.1016\/j.intimp.2026.117240_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00617","article-title":"Coordinated modulation of energy metabolism and inflammation by branched-chain amino acids and fatty acids [internet]","author":"Ye","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0770","article-title":"IL-1R-IRAKM-Slc25a1 signaling axis reprograms lipogenesis in adipocytes to promote diet-induced obesity in mice","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.intimp.2026.117240_bb0775","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1017\/S0007114520000380","article-title":"Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism","volume":"123","author":"Amabebe","year":"2020","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.intimp.2026.117240_bb0780","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41368-022-00163-7","article-title":"Oral microbiota in human systematic diseases [internet]","author":"Peng","year":"2022","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.intimp.2026.117240_bb0785","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.590370","article-title":"Microbiota transplant in the treatment of obesity and diabetes: current and future perspectives [internet]","author":"Napolitano","year":"2020","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0790","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43622-3","article-title":"Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"issue":"7978","key":"10.1016\/j.intimp.2026.117240_bb0795","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41586-023-06466-x","article-title":"Gut microbial carbohydrate metabolism contributes to insulin resistance","volume":"621","author":"Takeuchi","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0800","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-023-01637-4","article-title":"Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome","volume":"11","author":"Newman","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.intimp.2026.117240_bb0845","article-title":"Potential mechanisms of natural metabolites and botanical drugs foumulae for the treatment of non-alcoholic fatty liver disease: targeting the gut microbiota to modulate the immune system","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"23","key":"10.1016\/j.intimp.2026.117240_bb0860","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.70278","article-title":"TMAO accumulation induced by hyperglycemia triggers endoplasmic reticulum stress in the mouse liver","volume":"69","author":"Gao","year":"2025","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.intimp.2026.117240_bb0865","article-title":"Unraveling the mysteries of the gut-kidney axis: the protective role of traditional Chinese medicine in chronic kidney disease","volume":"16","author":"Li","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb0830","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1682755","article-title":"Molecular mechanisms and clinical applications of gut microbiota-derived bioactive compounds in metabolic dysfunction-associated fatty liver disease","volume":"16","author":"Ma","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0805","doi-asserted-by":"crossref","first-page":"834485","DOI":"10.3389\/fcimb.2022.834485","article-title":"Gut microbiota: an important player in type 2 diabetes mellitus [internet]","author":"Zhou","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb0810","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases [Internet]","author":"Hou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117240_bb0815","doi-asserted-by":"crossref","DOI":"10.1186\/s13293-021-00378-z","article-title":"Sex differences in the intestinal microbiome: interactions with risk factors for atherosclerosis and cardiovascular disease [internet]","author":"Ahmed","year":"2021","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.intimp.2026.117240_bb0820","article-title":"Gut microbiota regulate atherosclerosis via the gut-vascular axis: a scoping review of mechanisms and therapeutic interventions [internet]","author":"Zhang","year":"2025","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117240_bb0825","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2478\/jtim-2023-0116","article-title":"Impact of gut microbiota and associated mechanisms on postprandial glucose levels in patients with diabetes","volume":"11","author":"Feng","year":"2023","journal-title":"J. Translat. Internal Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0835","article-title":"Modulation of adipose tissue metabolism by microbial-derived metabolites [internet]","author":"Liu","year":"2022","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0840","doi-asserted-by":"crossref","DOI":"10.1096\/fba.2025-00218","article-title":"The gut microbiota\u2013insulin resistance axis: mechanisms, clinical implications, and therapeutic potential","volume":"8","author":"Qassab","year":"2026","journal-title":"FASEB Bioadv."},{"key":"10.1016\/j.intimp.2026.117240_bb0850","article-title":"Polydatin combined with hawthorn flavonoids alleviate high fat diet induced atherosclerosis by remodeling the gut microbiota and glycolipid metabolism","author":"Li","year":"2023","journal-title":"Research Square (Research Square)."},{"key":"10.1016\/j.intimp.2026.117240_bb0855","article-title":"Effects of oral glucose-lowering agents on gut microbiota and microbial metabolites [internet]","author":"Wang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb0875","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/CM9.0000000000000696","article-title":"Gut microbiota and metabolic syndrome [internet]","author":"Wang","year":"2020","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.intimp.2026.117240_bb1205","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.804455","article-title":"Taxonomic and functional fecal microbiota signatures associated with insulin resistance in non-diabetic subjects with overweight\/obesity within the frame of the PREDIMED-plus study","volume":"13","author":"Atzeni","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb0870","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3892\/ijmm.2020.4674","article-title":"Gut microbiota metabolites as integral mediators in cardiovascular diseases (review) [Internet]","author":"Zhu","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0880","article-title":"Zuogui Jiangtang Shuxin formula ameliorates diabetic cardiomyopathy mice via modulating gut-heart axis","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1075641","article-title":"Gut microbiota dependant trimethylamine N-oxide and hypertension [internet]","author":"Mutengo","year":"2023","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2026.117240_bb0890","series-title":"IntechOpen eBooks","article-title":"Dietary determinants of metabolic syndrome: focus on the obesity and metabolic dysfunction-associated Steatotic liver disease (MASLD)","author":"Verma","year":"2024"},{"key":"10.1016\/j.intimp.2026.117240_bb0895","article-title":"Interactions between gut microbiota, host, and herbal medicines: a review of new insights into the pathogenesis and treatment of type 2 diabetes [internet]","author":"Zheng","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb0900","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04088-5","article-title":"The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus [internet]","author":"A\u011fag\u00fcnd\u00fcz","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0905","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.578943","article-title":"Stachyose improves the effects of Berberine on glucose metabolism by regulating intestinal microbiota and short-chain fatty acids in spontaneous type 2 diabetic KKAy mice","volume":"11","author":"Cao","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117240_bb0910","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41564-023-01418-7","article-title":"Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid","volume":"8","author":"Wei","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb0915","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.616506","article-title":"Impaired intestinal barrier and tissue bacteria: pathomechanisms for metabolic diseases [internet]","author":"Massier","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0920","article-title":"Gut-derived imidazole propionate promotes atherosclerosis through myeloid imidazoline-1 receptor signaling: new biomarker and therapeutic target","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117240_bb0925","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-02004-x","article-title":"Targeted protein degradation: advances in drug discovery and clinical practice [Internet]","author":"Zhong","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.intimp.2026.117240_bb0930","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1038\/s41591-023-02635-7","article-title":"IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial","volume":"29","author":"Ackerman","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0935","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","article-title":"Targeting immunometabolism as an anti-inflammatory strategy [Internet]","author":"P\u00e5lsson-McDermott","year":"2020","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.117240_bb0940","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/acs.jmedchem.4c01322","article-title":"Interleukin-1 receptor-associated kinase 4 (IRAK4) degraders for treating inflammatory diseases: advances and prospects","volume":"68","author":"Lin","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.117240_bb0945","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.567899","article-title":"Drug discovery and development of novel therapeutics for inhibiting TMAO in models of atherosclerosis and diabetes [internet]","author":"Steinke","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2026.117240_bb0950","first-page":"360","article-title":"The role of the gut microbiome and its metabolites in metabolic diseases [Internet]","author":"Wu","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.intimp.2026.117240_bb0955","series-title":"IntechOpen eBooks","article-title":"Novel pathogenesis and treatments for cardiovascular disease [internet]","author":"Gaze","year":"2022"},{"key":"10.1016\/j.intimp.2026.117240_bb0960","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658354","article-title":"Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation [internet]","author":"Gasaly","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb0965","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-024-01012-x","article-title":"Gut microbiota-derived metabolites tune host homeostasis fate [Internet]","author":"Kim","year":"2024","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2026.117240_bb0970","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-022-01092-0","article-title":"Metabolic control by the microbiome [internet]","author":"Cox","year":"2022","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb0975","doi-asserted-by":"crossref","DOI":"10.1186\/s43162-024-00342-4","article-title":"Gut microbiota-derived metabolites: implications for metabolic syndrome and therapeutic interventions","volume":"36","author":"Olalekan","year":"2024","journal-title":"Egypt. J. Intern. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb0980","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.636175","article-title":"Roles of gut microbial metabolites in diabetic kidney disease [internet]","author":"Fang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb0985","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-00999-9","article-title":"PROTACs: great opportunities for academia and industry (an update from 2020 to 2021) [internet]","author":"He","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117240_bb0990","article-title":"An overview of PROTACs: a promising drug discovery paradigm [internet]","author":"Zi","year":"2022","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.intimp.2026.117240_bb0995","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1665747","article-title":"Editorial: interactions between tissues and kingdoms and interplay with environmental factors: impact on metabolic health and diseases","volume":"16","author":"Abruzzese","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb1000","article-title":"Microbiota: a potential orchestrator of antidiabetic therapy [internet]","author":"Liu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb1005","article-title":"Microbiome-based therapeutics for metabolic disorders: harnessing microbial intrusions for treatment","volume":"7","author":"Ahmed","year":"2025","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.intimp.2026.117240_bb1010","first-page":"55","article-title":"Gut microbiota in human metabolic health and disease [internet]","author":"Fan","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb1015","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1169624","article-title":"Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease [internet]","author":"Masse","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb1020","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-022-01264-5","article-title":"Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity","volume":"10","author":"M\u00fcnzker","year":"2022","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb1025","doi-asserted-by":"crossref","DOI":"10.1186\/s13099-025-00749-6","article-title":"Global research landscape and advancements on the links between the gut microbiome and insulin resistance: hot issues, trends, future directions, and bibliometric analysis","volume":"17","author":"Zyoud","year":"2025","journal-title":"Gut Pathog."},{"key":"10.1016\/j.intimp.2026.117240_bb1030","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets [Internet]","author":"Fleishman","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117240_bb1035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1193373","article-title":"Uncoupling hepatic insulin resistance \u2013 hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes [internet]","author":"Niranjan","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb1040","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1637071","article-title":"\u201cTrust your gut\u201d: exploring the connection between gut microbiome dysbiosis and the advancement of metabolic associated steatosis liver disease (MASLD)\/metabolic associated steatohepatitis (MASH): a systematic review of animal and human studies [internet]","author":"Bahitham","year":"2025","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2026.117240_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111836","article-title":"Western diet\u2013induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: features of gut microbiome-liver-adipose tissue axis","author":"Romualdo","year":"2022","journal-title":"Nutrition"},{"key":"10.1016\/j.intimp.2026.117240_bb1050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders [internet]","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2026.117240_bb1055","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-022-00810-w","article-title":"Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases [internet]","author":"Liu","year":"2022","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb1060","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-023-01469-2","article-title":"The diet rapidly and differentially affects the gut microbiota and host lipid mediators in a healthy population","volume":"11","author":"Bourdeau-Julien","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.intimp.2026.117240_bb1065","article-title":"Interaction mechanism and intervention strategy between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota [internet]","author":"Yang","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb1070","article-title":"Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives [Internet]","author":"Lin","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb1075","first-page":"74","article-title":"Harnessing AI and gut microbiome research for precision health","volume":"3","author":"Saxena","year":"2024","journal-title":"Deleted J."},{"key":"10.1016\/j.intimp.2026.117240_bb1080","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1007\/s10238-023-01064-7","article-title":"Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm [Internet]","author":"Mahmoud","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"20","key":"10.1016\/j.intimp.2026.117240_bb1085","doi-asserted-by":"crossref","first-page":"18022","DOI":"10.1021\/acs.jmedchem.4c01305","article-title":"Discovery of KT-474a potent, selective, and orally bioavailable IRAK4 degrader for the treatment of autoimmune diseases","volume":"67","author":"Zheng","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.117240_bb1120","first-page":"31","article-title":"Microbiome and human health: current understanding, engineering, and enabling technologies [internet]","author":"Aggarwal","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.intimp.2026.117240_bb1125","article-title":"Targeting trimethylamine N-oxide: a new therapeutic strategy for alleviating atherosclerosis [internet]","author":"Jing","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb1130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2023.11.005","article-title":"Gut dysbiosis-related thrombosis in inflammatory bowel disease: potential disease mechanisms and emerging therapeutic strategies [internet]","author":"Papa","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2026.117240_bb1135","article-title":"Trimethylamine-N-oxide pathway: a potential target for the treatment of MAFLD [internet]","author":"Li","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.intimp.2026.117240_bb1140","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1007\/s00253-020-10599-8","article-title":"Archaea, specific genetic traits, and development of improved bacterial live biotherapeutic products: another face of next-generation probiotics [Internet]","author":"Fadhlaoui","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2026.117240_bb1090","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1632435","article-title":"The human microbiome in clinical translation: from bench to bedside [internet]","author":"Bautista","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb1095","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease [internet]","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2026.117240_bb1100","article-title":"Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: a systematic review and meta-analysis [internet]","author":"Pan","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117240_bb1105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.554961","article-title":"Multi-target approaches in metabolic syndrome [internet]","author":"Lillich","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117240_bb1110","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-025-05379-9","article-title":"Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms\u2013a comprehensive review [Internet]","author":"Xu","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2026.117240_bb1115","article-title":"Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers [internet]","author":"Zeng","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb1145","article-title":"The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives","author":"Li","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.intimp.2026.117240_bb1150","article-title":"TMAO as a potential biomarker and therapeutic target for chronic kidney disease: a review [internet]","author":"Ye","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb1155","doi-asserted-by":"crossref","first-page":"2604868","DOI":"10.1080\/19490976.2025.2604868","article-title":"Gut\u2013heart axis: emerging therapies targeting trimethylamine N-oxide production","volume":"18","author":"Torres","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.intimp.2026.117240_bb1160","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.903570","article-title":"The gut microbiota (microbiome) in cardiovascular disease and its therapeutic regulation [internet]","author":"Rahman","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb1165","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.530160","article-title":"Interactions between therapeutics for metabolic disease, cardiovascular risk factors, and gut microbiota [internet]","author":"Ding","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb1170","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-022-01973-4","article-title":"Machine learning for data integration in human gut microbiome [internet]","author":"Li","year":"2022","journal-title":"Microb. Cell Factories"},{"issue":"5","key":"10.1016\/j.intimp.2026.117240_bb1175","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.numecd.2021.01.007","article-title":"Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis","volume":"31","author":"Tian","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.intimp.2026.117240_bb1180","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-020-00813-7","article-title":"The complexities of the diet-microbiome relationship: advances and perspectives [internet]","author":"Leeming","year":"2021","journal-title":"Genome Med."},{"key":"10.1016\/j.intimp.2026.117240_bb1185","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.987104","article-title":"Emerging computational paradigms to address the complex role of gut microbial metabolism in cardiovascular diseases [internet]","author":"Aminian-Dehkordi","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb1190","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.00079","article-title":"A guide to diet-microbiome study design [internet]","author":"Johnson","year":"2020","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2026.117240_bb1195","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.977187","article-title":"The role and mechanisms of gut microbiota in diabetic nephropathy, diabetic retinopathy and cardiovascular diseases [internet]","author":"Lv","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb1200","first-page":"346","article-title":"Gut microbes in cardiovascular diseases and their potential therapeutic applications [Internet]","author":"Jin","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.intimp.2026.117240_bb1210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1370658","article-title":"Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases","volume":"15","author":"Niu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb1215","article-title":"Function of Akkermansia muciniphila in type 2 diabetes and related diseases [internet]","author":"Li","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb1220","article-title":"Function of Akkermansia muciniphila in obesity: interactions with lipid metabolism, immune response and gut systems [internet]","author":"Xu","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2026.117240_bb1225","article-title":"Function and therapeutic prospects of next-generation probiotic Akkermansia muciniphila in infectious diseases","volume":"15","author":"Li","year":"2024","journal-title":"Front. Microbiol."},{"issue":"17","key":"10.1016\/j.intimp.2026.117240_bb1230","doi-asserted-by":"crossref","first-page":"1856667","DOI":"10.3389\/fendo.2026.1856667","article-title":"Gut microbiota in type 2 diabetes mellitus: mechanistic links between dysbiosis, insulin resistance, and chronic low-grade inflammation","volume":"2","author":"Chen","year":"2026","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb1235","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-022-03631-0","article-title":"The potential impact of a probiotic: Akkermansia muciniphila in the regulation of blood pressure\u2014the current facts and evidence [internet]","author":"Lakshmanan","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb1240","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1565609","article-title":"An overview of basic pathophysiological interactions between gut bacteria and their host [internet]","author":"Simonson","year":"2025","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2026.117240_bb1245","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1665101","article-title":"Akkermansia muciniphila and osteoporosis: emerging role of gut microbiota in skeletal homeostasis [internet]","author":"Gong","year":"2025","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb1250","doi-asserted-by":"crossref","first-page":"1849998","DOI":"10.1080\/19490976.2020.1849998","article-title":"From correlation to causality: the case of Subdoligranulum","volume":"12","author":"Hul","year":"2020","journal-title":"Gut Microbes"},{"issue":"8","key":"10.1016\/j.intimp.2026.117240_bb1255","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/nu15081815","article-title":"Role of akkermansia in human diseases: from causation to therapeutic properties","volume":"15","author":"Pellegrino","year":"2023","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.intimp.2026.117240_bb1260","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/gidisord7040072","article-title":"Akkermansia muciniphila in cardiometabolic medicine: mechanisms, clinical studies, and therapeutic outlook","volume":"7","author":"FakhriRavari","year":"2025","journal-title":"Gastrointes. Disorders"},{"key":"10.1016\/j.intimp.2026.117240_bb1270","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets [internet]","author":"Qiu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117240_bb1275","doi-asserted-by":"crossref","first-page":"100010","DOI":"10.1016\/j.aspetd.2025.100010","article-title":"Pharmacological modulation of the gut microbiota and endotoxemia: a next-generation approach to treating metabolic syndrome","volume":"1","author":"Dimeji","year":"2025","journal-title":"ASPET Discov."},{"key":"10.1016\/j.intimp.2026.117240_bb1280","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11154-023-09821-5","article-title":"Precision nutrition for targeting pathophysiology of cardiometabolic phenotypes [Internet]","author":"Shannon","year":"2023","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.intimp.2026.117240_bb1285","series-title":"The Role of Akkermansia muciniphila in human health: a clinical review","author":"FakhriRavari","year":"2025"},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb1290","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-62506-w","article-title":"Bofutsushosan improves gut barrier function with a bloom of Akkermansia muciniphila and improves glucose metabolism in mice with diet-induced obesity","volume":"10","author":"Fujisaka","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117240_bb1295","first-page":"2","article-title":"A complete guide to human microbiomes: body niches, transmission, development, dysbiosis, and restoration","author":"Reynoso-Garc\u00eda","year":"2022","journal-title":"Front. Syst. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb1300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6065\/apem.2040188.094","article-title":"Role of obesity-induced inflammation in the development of insulin resistance and type 2 diabetes: history of the research and remaining questions","volume":"26","author":"Kim","year":"2021","journal-title":"Annals Pediatr. Endocrinol. Metabol."},{"key":"10.1016\/j.intimp.2026.117240_bb1305","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.602088","article-title":"Adipose tissue immunomodulation: a novel therapeutic approach in cardiovascular and metabolic diseases [internet]","author":"AlZaim","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb1310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.592949","article-title":"Interaction of adipocyte metabolic and immune functions through TBK1 [internet]","author":"Zhao","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb1315","article-title":"Innate immune system orchestrates metabolic homeostasis and dysfunction in visceral adipose tissue during obesity [internet]","author":"Yu","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb1320","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30646-4","article-title":"Multiomics reveals persistence of obesity-associated immune cell phenotypes in adipose tissue during weight loss and weight regain in mice","volume":"13","author":"Cottam","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117240_bb1325","first-page":"421","article-title":"Resident and migratory adipose immune cells control systemic metabolism and thermogenesis [internet]","author":"Man","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb1330","article-title":"The diverse roles of macrophages in metabolic inflammation and its resolution [internet]","author":"Ray","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.117240_bb1335","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00259","article-title":"Macrophage subsets in obesity, aligning the liver and adipose tissue [internet]","author":"Remmerie","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117240_bb1340","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-025-05399-5","article-title":"Metabolomics of abdominal adipose tissue samples collected from patients with obesity \u2013 a critical review [Internet]","author":"Jaroch","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2026.117240_bb1345","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s11739-023-03262-3","article-title":"Are gut dysbiosis, barrier disruption, and endotoxemia related to adipose tissue dysfunction in metabolic disorders? Overview of the mechanisms involved [Internet]","author":"Silva","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.intimp.2026.117240_bb1350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.668654","article-title":"Obesity in humans is characterized by gut inflammation as shown by pro-inflammatory intestinal macrophage accumulation","volume":"12","author":"Rohm","year":"2021","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.intimp.2026.117240_bb1355","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.171701","article-title":"A lipid-associated macrophage lineage rewires the spatial landscape of adipose tissue in early obesity","volume":"8","author":"Stansbury","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb1360","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78015-9","article-title":"Generation of immune cell containing adipose organoids for in vitro analysis of immune metabolism","volume":"10","author":"Taylor","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117240_bb1365","article-title":"The roles of adipose tissue macrophages in human disease [internet]","author":"Liang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb1370","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1373182","article-title":"History and future perspectives of adipose tissue macrophage biology","volume":"15","author":"Kado","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117240_bb1375","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-024-00612-x","article-title":"Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease [internet]","author":"Lu","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.intimp.2026.117240_bb1380","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.it.2021.07.006","article-title":"Regional specialization of macrophages along the gastrointestinal tract [internet]","author":"Berthold","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb1385","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20220200","article-title":"Adipose tissue macrophages and their role in obesity-associated insulin resistance: an overview of the complex dynamics at play [internet]","author":"Guria","year":"2023","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.intimp.2026.117240_bb1390","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-07075-0","article-title":"Macrophage polarization in diabetic vascular complications: mechanistic insights and therapeutic targets [internet]","author":"Cao","year":"2025","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117240_bb1395","doi-asserted-by":"crossref","DOI":"10.1097\/IN9.0000000000000069","article-title":"Immunometabolism at the crossroads of infection: mechanistic and systems-level perspectives from host and pathogen","volume":"7","author":"Malla","year":"2025","journal-title":"Immunometabolism"},{"key":"10.1016\/j.intimp.2026.117240_bb1400","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-020-01342-3","article-title":"A review on the biology and properties of adipose tissue macrophages involved in adipose tissue physiological and pathophysiological processes [internet]","author":"Li","year":"2020","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117240_bb1405","article-title":"Improvement of obesity-associated disorders by a small-molecule drug targeting mitochondria of adipose tissue macrophages","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117240_bb1410","first-page":"337","article-title":"Impact of intracellular innate immune receptors on immunometabolism [internet]","author":"Chou","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.117240_bb1415","first-page":"42","article-title":"The role of cell metabolism in innate immune memory [internet]","author":"Ferreira","year":"2020","journal-title":"J. Innate Immun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:38:36Z","timestamp":1790437116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926010866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":282,"alternative-id":["S1567576926010866"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117240","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota-derived TMA\/TMAO and IRAK4 signaling in type 2 diabetes: Current evidence, knowledge gaps and future therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117240"}}